{"id":51,"date":"2025-10-13T19:54:18","date_gmt":"2025-10-13T17:54:18","guid":{"rendered":"https:\/\/europa-peptide.com\/?post_type=product&#038;p=51"},"modified":"2026-05-22T23:04:43","modified_gmt":"2026-05-22T21:04:43","slug":"tirzepatide-mounjaro","status":"publish","type":"product","link":"https:\/\/europa-peptide.com\/it\/shop\/tirzepatide-mounjaro\/","title":{"rendered":"Tirzepatide \/ Mounjaro"},"content":{"rendered":"<p data-start=\"0\" data-end=\"80\"><strong data-start=\"0\" data-end=\"78\">Tirzepatide - Peptide a doppia azione per la gestione del metabolismo e del peso<\/strong><\/p>\n<p data-start=\"82\" data-end=\"305\"><strong data-start=\"82\" data-end=\"98\">Composizione:<\/strong>\u00a0Tirzepatide (polvere peptidica liofilizzata)<br data-start=\"145\" data-end=\"148\" \/><strong data-start=\"148\" data-end=\"161\">Categoria:<\/strong> Peptide<br data-start=\"169\" data-end=\"172\" \/><strong data-start=\"172\" data-end=\"181\">Forma:<\/strong> Fiala con polvere liofilizzata<br data-start=\"211\" data-end=\"214\" \/><strong data-start=\"214\" data-end=\"233\">Amministrazione:<\/strong> Iniezione sottocutanea dopo ricostituzione con acqua batteriostatica<\/p>\n<hr data-start=\"307\" data-end=\"310\" \/>\n<h3 data-start=\"312\" data-end=\"336\">Che cos'\u00e8 la tirzepatide?<\/h3>\n<p data-start=\"337\" data-end=\"759\"><strong data-start=\"337\" data-end=\"352\">Tirzepatide<\/strong> \u00e8 un <strong data-start=\"358\" data-end=\"392\">agonista doppio del recettore dell'incretina<\/strong> che attiva contemporaneamente il <strong data-start=\"427\" data-end=\"462\">GLP-1 (peptide simile al glucagone-1)<\/strong>e <strong data-start=\"467\" data-end=\"521\">GIP (Polipeptide insulinotropico dipendente dal glucosio)<\/strong> recettori.<br data-start=\"532\" data-end=\"535\" \/>Questo doppio meccanismo lo rende un <strong data-start=\"566\" data-end=\"593\">peptide di nuova generazione<\/strong> in <strong data-start=\"597\" data-end=\"641\">ricerca sulla regolazione del metabolismo e del peso<\/strong>, combinando il <strong data-start=\"657\" data-end=\"703\">effetti di riduzione del glucosio degli agonisti del GLP-1<\/strong> con il <strong data-start=\"713\" data-end=\"757\">vantaggi metabolici della stimolazione della GIP.<\/strong><\/p>\n<p data-start=\"761\" data-end=\"976\">Attivando entrambe le vie di segnalazione, la tirzepatide ha dimostrato un forte potenziale nel <strong data-start=\"842\" data-end=\"878\">studi preclinici e clinici<\/strong> per migliorare <strong data-start=\"893\" data-end=\"936\">sensibilit\u00e0 all'insulina, riducendo il grasso corporeo,<\/strong> e ottimizzando <strong data-start=\"952\" data-end=\"974\">metabolismo energetico.<\/strong><\/p>\n<p data-start=\"978\" data-end=\"1070\">\u27a1\ufe0f Ideale per <strong data-start=\"991\" data-end=\"1032\">salute metabolica, regolazione dell'insulina,<\/strong> e <strong data-start=\"1037\" data-end=\"1068\">ricerca sui meccanismi dell'obesit\u00e0.<\/strong><\/p>\n<hr data-start=\"1072\" data-end=\"1075\" \/>\n<h3 data-start=\"1077\" data-end=\"1102\">Principali risultati della ricerca<\/h3>\n<p data-start=\"1104\" data-end=\"1222\"><strong data-start=\"1104\" data-end=\"1133\">Attivazione del doppio recettore:<\/strong> Stimola sia <strong data-start=\"1150\" data-end=\"1159\">GLP-1<\/strong> e <strong data-start=\"1164\" data-end=\"1181\">Recettori GIP<\/strong> per un potenziamento metabolico sinergico.<\/p>\n<p data-start=\"1224\" data-end=\"1318\"><strong data-start=\"1224\" data-end=\"1247\">Regolazione del glucosio:<\/strong> Promuove <strong data-start=\"1257\" data-end=\"1278\">secrezione di insulina<\/strong> e migliora <strong data-start=\"1292\" data-end=\"1316\">omeostasi del glucosio.<\/strong><\/p>\n<p data-start=\"1320\" data-end=\"1410\"><strong data-start=\"1320\" data-end=\"1338\">Riduzione del grasso:<\/strong> Porta a <strong data-start=\"1348\" data-end=\"1370\">riduzione del grasso corporeo<\/strong> mantenendo <strong data-start=\"1389\" data-end=\"1408\">massa magra.<\/strong><\/p>\n<p data-start=\"1412\" data-end=\"1500\"><strong data-start=\"1412\" data-end=\"1433\">Controllo dell'appetito:<\/strong> Regola i meccanismi centrali che controllano <strong data-start=\"1475\" data-end=\"1498\">fame e saziet\u00e0.<\/strong><\/p>\n<p data-start=\"1502\" data-end=\"1587\"><strong data-start=\"1502\" data-end=\"1524\">Metabolismo energetico:<\/strong> Migliora <strong data-start=\"1534\" data-end=\"1562\">efficienza mitocondriale<\/strong> e <strong data-start=\"1567\" data-end=\"1585\">ossidazione dei grassi.<\/strong><\/p>\n<hr data-start=\"1589\" data-end=\"1592\" \/>\n<h3 data-start=\"1594\" data-end=\"1618\">Dosaggio e applicazione<\/h3>\n<p data-start=\"1619\" data-end=\"1675\">Ricostituire con <strong data-start=\"1637\" data-end=\"1661\">acqua batteriostatica<\/strong> prima dell'uso.<\/p>\n<p data-start=\"1677\" data-end=\"1803\">Gamma di ricerca tipica: <strong data-start=\"1701\" data-end=\"1732\">0,25-1,0 mg per applicazione<\/strong>, per via sottocutanea, <strong data-start=\"1750\" data-end=\"1774\">una o due volte alla settimana<\/strong> a seconda del disegno dello studio.<\/p>\n<p data-start=\"1805\" data-end=\"1884\">Conservare la soluzione ricostituita <strong data-start=\"1838\" data-end=\"1854\">refrigerato<\/strong> e l'utilizzo all'interno di <strong data-start=\"1870\" data-end=\"1882\">30 giorni.<\/strong><\/p>\n<hr data-start=\"1886\" data-end=\"1889\" \/>\n<h3 data-start=\"1891\" data-end=\"1915\">Istruzioni per la conservazione<\/h3>\n<ul data-start=\"1916\" data-end=\"2047\">\n<li data-start=\"1916\" data-end=\"1950\">\n<p data-start=\"1918\" data-end=\"1950\">Conservare presso <strong data-start=\"1927\" data-end=\"1948\">2-8 \u00b0C (36-46 \u00b0F)<\/strong><\/p>\n<\/li>\n<li data-start=\"1951\" data-end=\"1990\">\n<p data-start=\"1953\" data-end=\"1990\">Proteggere da <strong data-start=\"1966\" data-end=\"1988\">luce e umidit\u00e0<\/strong><\/p>\n<\/li>\n<li data-start=\"1991\" data-end=\"2012\">\n<p data-start=\"1993\" data-end=\"2012\"><strong data-start=\"1993\" data-end=\"2010\">Non congelare<\/strong><\/p>\n<\/li>\n<li data-start=\"2013\" data-end=\"2047\">\n<p data-start=\"2015\" data-end=\"2047\">Evitare le fluttuazioni di temperatura<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"2049\" data-end=\"2052\" \/>\n<h3 data-start=\"2054\" data-end=\"2081\">Perch\u00e9 scegliere la tirzepatide?<\/h3>\n<p data-start=\"2082\" data-end=\"2463\"><strong data-start=\"2082\" data-end=\"2097\">Tirzepatide<\/strong> \u00e8 uno dei <strong data-start=\"2112\" data-end=\"2153\">i pi\u00f9 avanzati peptidi a base di incretina<\/strong> attualmente in fase di ricerca.<br data-start=\"2179\" data-end=\"2182\" \/>Attraverso il suo <strong data-start=\"2194\" data-end=\"2222\">attivazione del doppio recettore<\/strong>, offre un <strong data-start=\"2236\" data-end=\"2254\">profilo unico<\/strong> per l'ottimizzazione <strong data-start=\"2269\" data-end=\"2313\">controllo metabolico e gestione del peso.<\/strong><br data-start=\"2313\" data-end=\"2316\" \/>I suoi effetti su <strong data-start=\"2331\" data-end=\"2369\">metabolismo del glucosio, ossidazione dei grassi,<\/strong> e <strong data-start=\"2374\" data-end=\"2392\">bilancio energetico<\/strong> renderlo un <strong data-start=\"2403\" data-end=\"2420\">strumento prezioso<\/strong> in <strong data-start=\"2424\" data-end=\"2461\">ricerca endocrina e metabolica.<\/strong><\/p>\n<p data-start=\"2465\" data-end=\"2568\" data-is-last-node=\"\" data-is-only-node=\"\"><strong data-start=\"2467\" data-end=\"2494\">Ordinare Tirzepatide<\/strong>\u00a0ed esplorare il suo potenziale in <strong data-start=\"2524\" data-end=\"2568\" data-is-last-node=\"\">ricerca avanzata sul metabolismo e l'obesit\u00e0.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"<p>Tirzepatide \u00a0\u2013 Dual-Agonist Peptide for Metabolic &amp; Weight Management Composition:\u00a0Tirzepatide (lyophilized peptide powder)Category: PeptideForm: Vial with freeze-dried powderAdministration: Subcutaneous injection after reconstitution with bacteriostatic water What is Tirzepatide? Tirzepatide is a dual incretin receptor agonist that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1)and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors.This dual mechanism makes it a next-generation peptide in metabolic and weight regulation research, combining the glucose-lowering effects of GLP-1 agonists with the metabolic advantages of GIP stimulation. By activating both signaling pathways, Tirzepatide has shown strong potential in preclinical and clinical studies for improving insulin sensitivity, reducing body fat, and optimizing energy metabolism. \u27a1\ufe0f Ideal for metabolic health, insulin regulation, and obesity mechanism research. Key Research Findings Dual Receptor Activation: Stimulates both GLP-1 and GIP receptors for synergistic metabolic enhancement. Glucose Regulation: Promotes insulin secretion and improves glucose homeostasis. Fat Reduction: Leads to body fat reduction while maintaining lean body mass. Appetite Control: Regulates central mechanisms controlling hunger and satiety. Energy Metabolism: Enhances mitochondrial efficiency and fat oxidation. Dosage &amp; Application Reconstitute with bacteriostatic water before use. Typical research range: 0.25\u20131.0 mg per application, subcutaneously, once or twice weekly depending on study design. Store the reconstituted solution refrigerated and use within 30 days. Storage Instructions Store at 2\u20138 \u00b0C (36\u201346 \u00b0F) Protect from light and moisture Do not freeze Avoid temperature fluctuations Why Choose Tirzepatide? Tirzepatide is one of the most advanced incretin-based peptides currently under research.Through its dual receptor activation, it offers a unique profile for optimized metabolic control and weight management.Its effects on glucose metabolism, fat oxidation, and energy balance make it a valuable tool in endocrine and metabolic research. Order Tirzepatide\u00a0and explore its potential in advanced metabolic and obesity research.<\/p>","protected":false},"featured_media":64,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[17,24,25,27],"product_tag":[],"class_list":{"0":"post-51","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-all-products","7":"product_cat-glp-1andmultiagonist","8":"product_cat-metabolismandweightmanagement","9":"product_cat-peptidesandresearchdrugs","10":"entry","11":"has-media","13":"first","14":"instock","15":"purchasable","16":"product-type-variable"},"acf":[],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product\/51","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/comments?post=51"}],"version-history":[{"count":3,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product\/51\/revisions"}],"predecessor-version":[{"id":39659,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product\/51\/revisions\/39659"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/media\/64"}],"wp:attachment":[{"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/media?parent=51"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product_brand?post=51"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product_cat?post=51"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europa-peptide.com\/it\/wp-json\/wp\/v2\/product_tag?post=51"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}